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Abstract
Introduction: Mammographic density is a strong breast cancer risk factor and a major determinant of screening
sensitivity. However, there is currently no validated estimation method for full-field digital mammography (FFDM).
Methods: The performance of three area-based approaches (BI-RADS, the semi-automated Cumulus, and the
fully-automated ImageJ-based approach) and three fully-automated volumetric methods (Volpara, Quantra and
single energy x-ray absorptiometry (SXA)) were assessed in 3168 FFDM images from 414 cases and 685 controls. Linear
regression models were used to assess associations between breast cancer risk factors and density among controls,
and logistic regression models to assess density-breast cancer risk associations, adjusting for age, body mass index
(BMI) and reproductive variables.
Results: Quantra and the ImageJ-based approach failed to produce readings for 4% and 11% of the participants.
All six density assessment methods showed that percent density (PD) was inversely associated with age, BMI, being
parous and postmenopausal at mammography. PD was positively associated with breast cancer for all methods,
but with the increase in risk per standard deviation increment in PD being highest for Volpara (1.83; 95% CI: 1.51
to 2.21) and Cumulus (1.58; 1.33 to 1.88) and lower for the ImageJ-based method (1.45; 1.21 to 1.74), Quantra
(1.40; 1.19 to 1.66) and SXA (1.37; 1.16 to 1.63). Women in the top PD quintile (or BI-RADS 4) had 8.26 (4.28 to
15.96), 3.94 (2.26 to 6.86), 3.38 (2.00 to 5.72), 2.99 (1.76 to 5.09), 2.55 (1.46 to 4.43) and 2.96 (0.50 to 17.5) times the
risk of those in the bottom one (or BI-RADS 1), respectively, for Volpara, Quantra, Cumulus, SXA, ImageJ-based
method, and BI-RADS (P for trend <0.0001 for all). The ImageJ-based method had a slightly higher ability to
discriminate between cases and controls (area under the curve (AUC) for PD = 0.68, P = 0.05), and Quantra slightly
lower (AUC = 0.63; P = 0.06), than Cumulus (AUC = 0.65).
Conclusions: Fully-automated methods are valid alternatives to the labour-intensive “gold standard” Cumulus
for quantifying density in FFDM. The choice of a particular method will depend on the aims and setting but the
same approach will be required for longitudinal density assessments.
Introduction
Mammographic density is one of the strongest breast
cancer risk factors [1,2], which is being increasingly used
to tailor preventive and screening strategies to a woman’s
risk. It is also a major determinant of sensitivity of mam-
mographic screening and, thus, of interval cancer rates
[3,4]. Consequently, in many US states, it is now man-
datory to inform screening-attendees of their density.
There are several area-based [5-10] and volumetric
[11-14] approaches to measuring density in screen-film
mammography, but the quantitative semi-automated
Cumulus approach is regarded as the gold standard, as
its area-based measurements have consistently been
shown to be strongly associated with breast cancer risk
[2]. Screen-film mammography is gradually being replaced
by full-field digital mammography (FFDM), and fully auto-
mated volumetric methods have been developed for density
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assessment on digital images [15-17] but to date, evalu-
ation of their performance has been limited to establishing
whether their measurements correlate with those from
more established methods, such as BI-RADS or Cumulus,
or to evaluating the extent to which they are associated
with breast cancer risk factors [15-18].
We conducted the first comparison of the ability of six
methods of mammographic density measurement to pre-
dict breast cancer risk, including well-established analogue
methods adapted for, and novel methods developed
for FFDM.
Methods
Study population
Cases were women with newly diagnosed breast cancer
in the Royal Marsden Hospital (RMH), London, between
April 2010 and July 2012. Controls were women who
attended routine screening at the Central and East
London Breast Screening Service (CELBSS) during the
same period and were found to be breast cancer free.
CELBSS is part of the England and Wales national
mammographic screening programme offered once every
three years to women aged 50 (47 from 2012) to 70 years
(older women can self-refer) [19]. Women with a history of
breast or ovarian cancer, or with breast implants, were
excluded. The study was approved by all relevant ethics
committees (Research Ethics Committees from the Royal
Marsden Hospital, the Barts and the London NHS Trust,
and the London School of Hygiene and Tropical Medicine).
Participants provided written informed consent.
Data collection
Data on breast cancer risk factors (Table 1) were collected
by questionnaire at the time of screening for controls and
after diagnostic confirmation for cases (up to 15½months
after mammography), and complemented with data from
clinical records. Participants underwent two-view (stand-
ard cranio-caudal (CC) and medio-lateral oblique (MLO))
FFDM on each breast using Senographe DS units (GE
Healthcare, Slough, England).
Density readings were performed on anonymised images
from both breasts in controls and from the unaffected
breast for cases (Figure 1). The area-based methods com-
prised: (i) visual assessment by two radiologists (SA, SV)
who together examined all the unaffected processed
images from each woman and gave a single BI-RADS
score (1: percent density (PD) <25%; 2: PD = 25 to 50%; 3:
PD = 51 to 75%; 4: PD >75%) [5]. A subset of 62 films was
re-read independently by the same two readers with an
interval of ≥6 months between the two readings; (ii)
semi-automated interactive threshold Cumulus v3 [6,7],
after conversion of raw digital images into analogue-like
ones. Readings were performed by a single observer (IdSS)
in batches, each containing a 7% random sample of all
participants as duplicates to allow assessment of intra-
observer reliability; and (iii) the ImageJ-based method, a
fully-automated approach, which attempts to mimic Cu-
mulus [8,20], after conversion of processed images into
analogue-like ones. The latter two methods estimated
area-based breast size, absolute density, absolute non-
density (all in cm2) and PD, separately for each image.
From raw images the volumetric methods, which were all
fully-automated, estimated breast, absolute dense and ab-
solute non-dense volumes (all in cm3), and PD. They com-
prised: (i) Volpara v1.0 (Matakina Technology Limited,
Wellington, New Zealand) [18], which yielded separate
density estimates for each CC/MLO image; (ii) R2 Quan-
tra v1.3 (Hologic, Bedford, MA, USA) [17], which com-
bined the information from both views to produce average
estimates for each unaffected breast; and (iii) the single
energy x-ray absorptiometry (SXA) method, v6.5 [12],
which required the fitting of a calibration phantom onto
the compression paddle of the x-ray machine and which to
date, can only process CC images (see Additional file 1 for
further details on the various density assessment methods).
Statistical methods
Appropriate transformations (square root for area-based
metrics and natural-log transformation for volumetric
metrics) were applied to normalise the distributions
generated by the five quantitative methods. Scatter and
Bland-Altman plots were used to compare the trans-
formed distributions separately for each view and breast
combination. Intra-method reliability (intraclass correl-
ation coefficient, ICC) of a single density value (left or
right image of a CC or MLO view), and of the left-right
average for that view, was estimated as the percentage of
the total variance due to between-subject variance
among control women. Intra-observer BI-RADS agree-
ment was assessed using weighted κ statistic (weights of
1, 0.67, 0.33 and 0 for categories 1 to 4 apart). Inter-
method correlation and rank agreement was assessed by
estimating the Spearman’s rank correlation coefficient (r)
and the proportion of control women classified in the
same, or the same ±1 adjacent, quintile.
Associations of breast cancer risk factors with PD, and
absolute density and non-density, were assessed among
controls, by linear regression models adjusting for age,
body mass index (BMI) and reproductive variables. Re-
gression coefficients represent the difference in each
density measure (in number of SDs on the transformed
scale) associated with a unit change in the explanatory
variable.
Logistic regression models were fitted to examine asso-
ciations between density and breast cancer risk, adjusting
for age, BMI, and reproductive variables (further adjust-
ment for ethnicity did not affect the results). For the
quantitative methods, the density measurements from
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the unaffected breast for cases and a randomly selected
breast for controls were included in the models as con-
tinuous variables (in SD scores) or as quintiles (defined
among controls). Sensitivity analyses included estimates
by view; restriction to participants with density readings
available for all quantitative methods; restriction to
those aged <80 years; and use of multiple imputation
methods to impute values for women with missing con-
founder data. The area under the curve (AUC) of the re-
ceiver operating characteristic curve was used to
compare the ability of the various quantitative methods to
discriminate between cases and controls. Analyses were
performed in Stata 13.1 [21]. All P-values are two-sided.
Results
In all, 463 cases and 727 controls were recruited (response
rate: 85% for cases, 51% for controls), but only 414 cases
and 685 controls were eligible (Figure 1). Cases were older
and more likely to be of white ethnicity than controls
(Table 1). Volpara and Cumulus produced readings for all
participants; missing readings for BI-RADS and SXA were
caused by logistical errors whereas those for the ImageJ-
based and Quantra approaches were intrinsic failures of
these methods (Figure 1). Women with missing readings
from the ImageJ-based, Quantra or SXA methods did not
differ from those with such readings in terms of their age,
BMI or reproductive factors but on average, those with
missing ImageJ-based readings had lower Cumulus PD
(median (inter-quartile range): 2.5% (0.8 to 5.6%) for
women with missing versus 8.7% (2.8 to 23.6%) for those
without missing readings, P <0.0001).
Inter- and intra-method comparisons among controls
PD distributions from the five quantitative methods were
right-skewed, particularly for the area-based approaches
which included a high proportion of women with zero
values (no measurable dense tissue) (Figure 2). Relative
Table 1 Baseline characteristics of the participants by
case–control status
Controls (n = 685) Cases (n = 414)
Age, years at mammography
Mean (SD) 59.5 (6.6) 67.5 (12.7)
Missing, n 6 2
Ethnicity
White, n (%) 520 (76.5) 370 (90.5)
Other, n (%) 160 (23.5) 39 (9.5)
Missing, n 5 5
Educational level
None, n (%) 15 (2.2) 10 (3.7)
Primary, n (%) 20 (3.0) 7 (2.6)
Secondary, n (%) 297 (43.9) 186 (68.4)
University, n (%) 344 (50.9) 69 (25.4)
Missing, n 9 142
Body mass index at mammographya, kg/m2
Mean (SD) 26.1 (5.6) 26.4 (4.9)
Missing, n 29 46
Age at menarche, yrs
<12, n (%) 141 (21.0) 81 (21.3)
12, n (%) 130 (19.4) 78 (20.5)
13, n (%) 168 (25.0) 87 (22.8)
14+, n (%) 232 (34.6) 135 (35.4)
Missing, n 14 33
Menopausal status at mammographyb
Pre- and perimenopausal, n (%) 91 (13.3) 55 (13.3)
Postmenopausal, n (%) 591 (86.7) 358 (86.7)
Missing, n 3 1
Ever use of oral contraceptives
Yes, n (%) 472 (70.5) 216 (55.2)
No, n (%) 198 (29.6) 175 (44.8)
Missing, n 15 23
Ever use of hormonal therapy
Yes, n (%) 208 (31.2) 143 (36.8)
No, n (%) 459 (68.8) 246 (63.2)
Missing, n 18 25
Nulliparity
No, n (%) 467 (69.1) 343 (84.1)
Yes, n (%) 209 (30.9) 65 (15.9)
Missing, n 9 6
Number of childrenc, n (%)
1 to 2 301 (65.4) 218 (64.9)
2 to 3 126 (27.4) 105 (31.3)
5+ 33 (7.2) 13 (3.9)
Table 1 Baseline characteristics of the participants by
case–control status (Continued)
Age at first birth, yrsc, n (%)
<20 83 (18.1) 25 (7.7)
20 to 30 258 (56.3) 213 (65.7)
30+ 117 (25.6) 86 (26.5)
Ever breastfedc, n (%)
Yes 358 (77.2) 224 (74.7)
No 106 (22.8) 76 (25.3)
aBody mass index estimated from self-reported height and weight as weight/
height2 (in kg/m2). bPostmenopausal women defined as those who self-reported
natural (that is, cessation of menses for at least 12 months) or surgical menopause,
were older than 55 years, or ever used hormone replacement therapy. Due to small
numbers pre- (that is, younger than 55 years and still having regular periods) and
perimenopausal (that is, younger than 55 years and having irregular periods)
women were combined into a single category. cRestricted to ever-parous women.
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to Cumulus, the ImageJ-based method yielded higher
PD estimates (Figure 2) due to overestimation of absolute
density and underestimation of breast area (see Additional
file 2: Figures S1, S2). Volumetric methods yielded nar-
rower PD distributions with no zero values. SXA produced
the highest estimates and Volpara the lowest (Figure 2),
paralleling similar between-method differences in the
estimation of absolute density (see Additional file 2:
Figures S1, S2). Over 92% of controls were classified as
BI-RADS 1 to 2 (Figure 2).
PD measurements from the four fully-automated
methods were strongly correlated with those produced
by the semi-automated Cumulus (r >0.77 for all; see
Additional file 2: Figure S3), mainly driven by strong
correlations for breast size (r >0.93 for all; Additional
file 2: Figure S5) as the corresponding correlations for
absolute density were weaker (r ≤0.41 except, as expected,
for strong ImageJ-based versus Cumulus correlation
(r = 0.90)); Additional file 2: Figure S4). Pair comparisons
of PD values yielded by the quantitative methods were high
(r from 0.76 (SXA-Volpara) to 0.92 (ImageJ-Cumulus))
(see Additional file 3: Table S1), with 47% and 66% of the
controls being classified in the same quintile and between
87% and 97% in the same ±1 quintile (see Additional file 3:
Table S2).
The PD distributions across breasts and views had a
similar shape but estimates were slightly higher for the
right breast for all quantitative methods, and for the CC
view for those that produced readings for both views
(see Additional file 3: Table S3), reflecting mainly between
breast/view differences in breast size. Both intra-observer
agreement for BI-RADS (k >0.80) and intra-reader reliabil-
ity for Cumulus (99% for breast area, 90% for PD and 87%
for dense area) were high. The reliability of PD measure-
ments based on a single film (ICC >0.84 for all) and on
the left-right mean (ICC >0.91) were high for all quan-
titative methods regardless of view, driven by very high
reliability for breast size (ICC for all methods: >0.93 for a
single film; >0.96 for left-right mean) but somewhat lower
for absolute density (see Additional file 3: Table S3).
Figure 1 Flowchart detailing the recruitment of study participants. aImages from both breasts in controls, and from the unaffected
contralateral breast only for cases. bPercentage of women with missing readings. AD, absolute area or volume of dense tissue; AND, absolute area
or volume of non-dense tissue; BS, breast size (area or volume); BC, breast cancer; FA, fully-automated method; OCa, ovarian cancer; PD, percent
density; SA, semi-automated method; VA, visual assessment.
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Associations with breast cancer risk factors among controls
The direction and magnitude (in SD numbers) of the PD
associations with breast cancer risk factors were remark-
ably similar across the five quantitative methods, and in
the direction expected, given the effects of these variables
on risk (Figure 3). All five quantitative methods showed
PD to be inversely associated with age. For Cumulus, this
age trend in PD reflects both an age decrease in absolute
density and an age increase in absolute non-density,
whereas for Volpara and the ImageJ-based method there
was only an age decrease in absolute density, and for SXA
only an increase in absolute non-density (see Additional
file 2: Figures S6, S7). For all methods there was a strong
inverse association of PD with BMI, driven by positive
association of BMI with absolute non-density for all
methods, as well as negative association of BMI with abso-
lute density for the two area-based methods. In contrast, a
trend of increasing dense volume with increasing BMI
was observed for all volumetric methods. PD was lower
among parous women for all quantitative methods, re-
flecting reductions in absolute density and also, for the
two area-based methods only, increases in absolute non-
density. PD was also lower among postmenopausal
women for all methods, driven by parallel declines in
absolute density. Ever-use of oral contraceptives was posi-
tively associated with increases in absolute density, but
only significantly so for the volumetric methods. There
were no associations with ever-use of hormonal therapy
(Figure 3; see Additional file 2: S6, S7), ages at menarche
or first birth, or educational level (not shown).
Mutually adjusted analyses showed that the odds of
having a BI-RADS score ≥3 relative to a score <3 de-
creased with increasing age (P for linear trend (Pt) = 0.06),
increasing BMI (Pt <0.0001) and being parous versus nul-
liparous (odds ratio (OR): 0.38; 95% CI 0.20, 0.74).
Breast cancer risk
All methods produced positive associations between PD
and breast cancer risk. Women in the top PD quintile
had 3.38 (95% CI 2.00, 5.72), 2.55 (1.46, 4.43), 8.26 (4.28,
15.96), 3.94 (2.26, 6.86) and 2.99 (1.76, 5.09) times
the risk of those in the bottom one, respectively, for
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Figure 2 Distribution of control participants by BI-RADS categories and percent density (PD) values yielded by each quantitative
method. *Density readings taken on the left cranio-caudal view (CC) except for BI-RADS, for which the four breasts/views were used to provide a
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Cumulus, ImageJ-based method, Volpara, Quantra and
SXA (Pt <0.0001 for all; Figure 4). The SXA OR was based
on CC, rather than CC-MLO average values but the
equivalent Volpara OR for the CC view was 6.18 (3.3,
11.42). The gradient in risk across quintiles was steeper
for Volpara, partly due to it being better at identifying
women at low risk than the area-based methods as dem-
onstrated by the lower number of cases that fell in the
bottom quintile. There was also a strong positive trend in
risk across BI-RADS categories but the magnitude of this
cannot be compared with those from the quantitative
methods (for example, BI-RADS score 1 encompassed the
bottom four Cumulus quintiles).
The positive association of risk with Cumulus-measured
PD reflected a positive association of risk with absolute
density and, to a lesser extent, a negative association of
risk with absolute non-density (Figure 5). In contrast, for
the ImageJ-based method, Volpara and SXA the positive
associations of risk with PD reflected mainly positive
associations of risk with absolute density, whereas for
Quantra it reflected mainly a negative association of risk
with absolute non-density (Figure 5).
Combining readings from pairs of fully-automated
volumetric methods did not affect the magnitude of the
PD-risk associations (Figure 6).
Risk increases per one SD increase in average PD were
consistently higher for Cumulus (1.58; 95% CI 1.33, 1.88)
than the ImageJ-based method (1.45; 1.21, 1.74), and for
Volpara (1.83; 1.51, 2.21) than the other volumetric
methods, Quantra (1.40; 1.19, 1.66) and SXA (1.37; 1.16,
1.63) (Table 2). The increases in risk associated with one
SD increase in absolute density were as high as those
associated with an equivalent increase in PD for the area-
based methods, but lower for the volumetric methods.
These findings were robust to a range of sensitivity ana-
lyses (Table 2).
The ImageJ-based method had slightly better ability to
discriminate between cases and controls of screening
Figure 3 Mutually-adjusted associations of known determinants of mammographic density with percent density (PD) readings in
control women. PD readings are the mean of four breast/view readings per woman (except for Quantra and single x-ray absorptiometry - see Methods).
BMI, body mass index; HT, hormonal therapy; OC, oral contraceptives; Pt, P for linear trend.
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age (50 to 69 years) (AUC for PD, age, BMI and re-
productive factors = 0.65, P = 0.05), and Quantra slightly
poorer (AUC for PD = 0.63, P = 0.06), than Cumulus
(AUC = 0.64) (see Additional file 3: Table S4). Similar
AUC values were observed for absolute density (see
Additional file 3: Table S4).
Discussion
Main findings
This study provides the most comprehensive compari-
son to date of the performance of alternative methods of
measuring mammographic density in FFDM images,
comprising both well-established and novel methods,
neither of which had been validated as predictors of risk
in these images. Despite differences in their density dis-
tributions, they all produced positive associations with
risk, which were strongest for Volpara and Cumulus.
These two methods were also the only ones to produce
readings for all images. Failure to produce readings
affects the power/precision of a study but, more worry-
ing, women with missing ImageJ-based values had lower
Cumulus PD than those for whom readings were avail-
able, a finding previously reported for analogue images
[20]. Such differences in missing values would bias the
estimation of the magnitude of the association between
the ImageJ-based PD values and risk, as women with
low PD values are more likely to be controls and
therefore their exclusion leads to underestimation of the
magnitude of the association. SXA readings were also
missing for a substantial proportion of participants due to
lack of a phantom, highlighting a practical limitation of
this method when implemented in busy clinical settings
(and the impossibility of applying it retrospectively to
historical images).
The majority of the participants had, in line with their
age and postmenopausal status, low PD and absolute
density according to all methods. However, the distribu-
tions of the volumetric PD estimates were narrower than
those of the area-based PD values, with the latter having a
high percentage of zero values, consistent with findings in
analogue images [20]. Area-based methods use an inten-
sity threshold to simply dichotomize breast pixels as being
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completely (100%) dense or non-dense (0% dense), whereas
volumetric methods quantify a continuous amount of dense
tissue at each pixel. The ImageJ-based method aims to
mimic the Cumulus approach [8], but it produced differ-
ent density distributions and, consistently with previous
observations in analogue images [20], its reliability was
lower and the association with risk weaker. There were
also differences in the density distributions produced
by the three volumetric methods, with Quantra and SXA
producing higher estimates. The lack of perfect between-
method rank correlation/agreement, although not unex-
pected as these methods may capture different density
dimensions, highlights the need to use the same approach
in longitudinal density assessments.
Consistent with other studies [1,22,23], PD was lower
in women who were older, parous, postmenopausal,
or had higher BMI, with the magnitude of the effects
(in SDs) being similar for all quantitative methods. The
PD decline with increasing BMI reflected a strong positive
trend of BMI with the non-dense area/volume of the
breast, which was consistent across all quantitative
methods. However, and akin to findings in analogue films
[20,23], whereas dense area was smaller at higher BMI,
dense volume was larger. Dense volume is equivalent to
volumetric PD multiplied by the total breast volume.
Thus, although women with higher BMI have lower
volumetric PD they also have larger breast volumes and,
hence, higher dense volumes than those with lower BMI.
All methods showed positive associations of PD with risk,
but with the magnitude being greatest for Volpara
and Cumulus. For Cumulus, the ImageJ-based method,
Volpara, and SXA the positive risk association with PD
reflected similar positive trends in risk with absolute
density whereas for Quantra it reflected mainly a nega-
tive trend in risk with absolute non-density. The Quantra
findings are difficult to explain as breast tumors arise pre-
dominantly within radio-dense tissue of the breast [24].
The ability to discriminate between cases and controls
was low (AUC: approximately 63 to 69%) for all methods,
albeit similar to that reported by others [8,20,25,26],
highlighting its limited value in individual risk prediction.
However, mammographic density might be useful, alone
or jointly with other risk factors, to stratify women in the
population according to risk for tailored interventions (for
example, screening).
The study did not aim to provide direct information
on the ease of incorporating any of the four fully auto-
mated density methods into screening/clinical practice as
it was designed to interfere as little as possible with the
usual routine. However, a few logistic issues emerged.
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Q3 (7.0)
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Q3 (38.6)
Q4 (47.7)
Q5 (59.3)
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0.68 (0.41, 1.11)
1.26 (0.80, 1.99)
1.88 (1.18, 2.99)
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0.98 (0.60, 1.60)
1.66 (1.03, 2.68)
1.72 (1.04, 2.85)
2.68 (1.62, 4.44)
1
1.21 (0.74, 1.99)
1.32 (0.81, 2.14)
1.97 (1.22, 3.19)
2.77 (1.72, 4.47)
1
0.90 (0.57, 1.42)
0.83 (0.52, 1.33)
0.99 (0.62, 1.57)
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Odd ratio (OR)
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Q4 (128.7)
Q5 (160.7)
Volpara (cm3)
Q1 (45.4)
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Q1 (23)
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Q4 (469)
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1.01 (0.59, 1.74)
0.94 (0.54, 1.66)
1.29 (0.72, 2.33)
1
0.90 (0.57, 1.44)
0.96 (0.60, 1.54)
1.01 (0.61, 1.68)
0.54 (0.29, 1.00)
1
1.05 (0.66, 1.66)
0.95 (0.59, 1.54)
0.99 (0.59, 1.65)
0.46 (0.25, 0.85)
1
1.02 (0.63, 1.64)
1.16 (0.71, 1.89)
1.00 (0.58, 1.70)
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Pt=0.13
Pt=0.02
Pt=0.31
1.4 8
No.
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No.
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Odd ratio (OR)
OR (95% CI)
Dense area/volume Non-dense area/volume
Figure 5 Breast cancer risk by fifths of absolute density and non-density for each quantitative method as defined by quintiles of the
distributions in controls. OR, odds ratio; Pt, P for linear trend; SXA, single energy x-ray absorptiometry.
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First, the methods were based on raw images, and thus,
required routinely saving them, and having the elec-
tronic data storage capacity to do so. Currently, only
processed images are routinely saved in most screening/
clinical settings but ongoing efforts to develop fully
automatic density measurement approaches for proc-
essed images may overcome this limitation in the future.
Second, although none of the methods required the use
of special equipment during image acquisition, with the
exception of SXA as discussed above, their software
requirements and output varied. Quantra (version 1.3)
produced for each participant, at the time of mammog-
raphy, a digital image with the density measurements
super-imposed on it, which is convenient in screening/
clinical settings, but not efficient in large-scale studies as
the density measurements for analysis will have to be
extracted manually from these images (Additional file 1).
Different versions of Volpara are available - a clinical ver-
sion, which provides readings during the examination, and
a research version which is appropriate for large-scale
collections. There are currently no stand-alone software
packages for either the SXA or the ImageJ-based method,
thus, limiting their widespread implementation.
Strengths and limitations of the study
Strengths of this study include the large number of density
assessment methods examined, the collection of covariates
at the time of mammography, and the BI-RADS and
Cumulus blind assessments. The study population was
predominantly postmenopausal, thus, limiting the gen-
eralisability of the findings to premenopausal women.
Similar between-method comparisons in younger women
with denser breasts - for whom accurate risk stratification
is more important - should be conducted. Response rates
were low for healthy controls and information on breast
cancer risk factors, including BMI, was self-reported;
however, any potential bias is likely to have been non-
differential as density is not routinely ascertained in
Volpara (%)
T1 (>5.1)
T2 (5.1-)
T3 (8.5+)
Quantra (%)
T1 (>13)
T2 (13-)
T3 (18+)
SXA (%)
T1 (>19.7)
T2 (19.7-)
T3 (30.4+)
Volpara & Quantra
1  (T1, T1)
2  (T1, T2)*
3  (T1, T3); (T2, T2); (T2,T3)*
4  (T3, T3)
Volpara & SXA
1  (T1, T1)
2  (T1, T2)*
3  (T1, T3); (T2, T2); (T2,T3)*
4  (T3, T3)
SXA & Quantra
1 (T1, T1)
2 (T1, T2)*
3 (T1, T3); (T2, T2); (T2,T3)*
4 (T3, T3)
67
155
141
81
143
136
100
137
123
47
49
144
120
48
69
130
113
60
56
134
107
No. 
Cases
217
216
214
217
198
200
192
191
191
175
73
197
170
127
114
190
143
128
117
176
134
No. 
Controls
1
2.96 (1.97, 4.45)
4.74 (2.93, 7.68)
1
2.28 (1.57, 3.32)
2.94 (1.94, 4.46)
1
1.46 (1.02, 2.09)
1.72 (1.15, 2.58)
1
2.52 (1.47, 4.30)
3.49 (2.23, 5.47)
5.60 (3.33, 9.40)
1
1.42 (0.87, 2.32)
2.13 (1.35, 3.37)
3.86 (2.27, 6.56)
1
0.95 (0.59, 1.54)
1.93 (1.26, 2.97)
2.94 (1.79, 4.84)
OR (95% CI)
Pt<0.0001
Pt<0.0001
Pt=0.01
Pt<0.0001
Pt<0.0001
Pt<0.0001
1.8 6
Odds ratio (OR)
Figure 6 Breast cancer risk associated with aggregated scores produced by combining readings from two fully-automated volumetric
methods. *Aggregated categories based on tertiles as defined among control women: 1: if classified in the bottom tertile (T1) by both methods;
2: if classified in T1 by one method but in the middle tertile (T2) by the other; 3: if classified in T1 by one method but in the top tertile (T3) by
the other, or in T2 by both methods, or in T2 by one method but in T3 by the other; 4: if classified in T3 by both methods. OR, odds ratio; Pt,
P for linear trend; SXA, single energy x-ray absorptiometry.
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Table 2 Mammographic density and breast cancer risk
Area-based methods Volumetric-based methods
Cumulus ImageJ-based method Volpara Quantra SXA
Percent density Number ORa (95% CI) Number ORa (95% CI) Number ORa (95% CI) Number ORa (95% CI) Number ORa (95% CI)
Average of CC and MLO readingsb 1,010 1.58 (1.33, 1.88) 891 1.45 (1.21, 1.74) 1,010 1.83 (1.51, 2.21) - - - - - -
Only CC readingsb 1,009 1.57 (1.32, 1.87) 888 1.33 (1.11, 1.59 1,009 1.75 (1.45, 2.10) 975 1.40 (1.19, 1.66) 934 1.37 (1.16, 1.63)
Only MLO readingsb 1,008 1.56 (1.31, 1.85) 882 1.42 (1.19, 1.69) 1,008 1.75 (1.44, 2.11) - - -
Multiple imputationc 1,095 1.63 (1.37, 1.93) 971 1.45 (1.22, 1.73) 1,095 1.82 (1.51, 2.20) 1,057 1.40 (1.19, 1.64) 1,014 1.35 (1.15, 1.60)
Restricted to women aged <80 yrs 948 1.58 (1.32, 1.88) 830 1.44 (1.20, 1.72) 948 1.78 (1.47, 2.15) 914 1.38 (1.17, 1.63) 874 1.36 (1.15, 1.62)
Restricted to women with data
for all quantitative methods
797 1.55 (1,29, 1.87) 797 1.52 (1.26, 1.84) 797 1.64 (1.33, 2.02) 797 1.26 (1.05, 1.55) 797 1.48 (1.22, 1.80)
Dense area/volume Number ORa (95% CI) Number ORa (95% CI) Number OR (95% CI) Number OR (95% CI) Number OR (95% CI)
Average of CC and MLO readingsb 1,010 1.57 (1.33, 1.84) 891 1.56 (1.31, 1.84) 1,010 1.46 (1.25, 1.70) - - - - - -
Only CC readingsb 1,009 1.58 (1.35, 1.86) 888 1.45 (1.23, 1.71) 1,009 1.47 (1.26, 1.72) 975 1.04 (0.88, 1.22) 934 1.26 (1.08, 1.47)
Only MLO readingsb 1,008 1.52 (1.30, 1.79) 882 1.49 (1.26, 1.77) 1,008 1.38 (1.18, 1.61) - - -
Multiple imputationc 1,095 1.60 (1.36, 1.87) 971 1.54 (1.31, 1.82) 1,095 1.43 (1.23, 1.66) 1,057 1.02 (0.87, 1.19) 1,014 1.23 (1.05, 1.43)
Restricted to women aged <80 yrs 948 1.57 (1.33, 1.84) 830 1.54 (1.31, 1.82) 948 1.49 (1.27, 1.74) 914 1.06 (0.89, 1.26) 874 1.27 (1.08, 1.49)
Restricted to women with data
for all quantitative methods
797 1.63 (1.36, 1.95) 797 1.62 (1.36, 1.94) 797 1.70 (1.42, 2.04) 797 1.23 (1.02, 1.49) 797 1.74 (1.43, 2.11)
Non-dense area/volume Number OR (95% CI) Number OR (95% CI) Number OR (95% CI) Number OR (95% CI) Number OR (95% CI)
Average of CC and MLO readingsb 1,010 0.69 (0.57, 0.84) 891 1.13 (0.93, 1.37) 1,010 0.85 (0.71, 1.03) - - - - - -
Only CC readingsb 1,009 0.74 (0.61, 0.90) 888 1.15 (0.95, 1.40) 1,009 0.88 (0.73, 1.06) 975 0.80 (0.66, 0.97) 934 0.90 (0.75, 1.08)
Only MLO readingsb 1,008 0.66 (0.54, 0.80) 882 1.08 (0.89, 1.30) 1,008 0.84 (0.69, 1.01) - - -
Multiple imputationc 1,095 0.67 (0.56, 0.82) 971 1.09 (0.90, 1.31) 1,095 0.83 (0.69, 1.01) 1,057 0.78 (0.65, 0.94) 1,014 0.87 (0.73, 1.04)
Restricted to women aged <80 yrs 948 0.69 (0.57, 0.84) 831 1.13 (0.93, 1.37) 948 0.88 (0.72, 1.07) 914 0.82 (0.68, 1.00) 874 0.91 (0.76, 1.10)
Restricted to women with data
for all quantitative methods
797 0.93 (0.74, 1.17) 797 1.12 (0.91, 1.37) 797 1.10 (0.88, 1.38) 797 1.03 (0.83, 1.28) 797 1.01 (0.81, 1.26)
This table presents the change in breast cancer risk associated with one standard deviation (SD) increase in percent density, absolute density and absolute non-density associated with each one of the five quantitative
methods. aOdds ratios (OR) and 95% CI as estimated by logistic regression models based on standardized values of transformed (log for volume-based methods and square root for area based methods adjusted for
age, body mass index (BMI), menopausal status and parity (see Methods). There was no evidence of departure from linearity. bBased on density measurements taken from the unaffected breast for cases and a random
breast side (left or right) for controls. Measurements for each of the two views were yielded by Cumulus, the ImageJ-based method and Volpara. Single energy x-ray absorptiometry (SXA) generated measurements
only for the CC view. Quantra combined data from both views to produce a single overall measurement for each breast (Figure 1). cMultiple imputation methods used to impute values for women with missing data
on age, BMI, menopausal status and/or parity (see Table 1 and Methods). CC, cranio-caudal view; MLO, medio-lateral oblique view; OR, odds ratios (with 95% confidence intervals).
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clinical/screening settings in the UK, and would have
affected all methods similarly. Analyses were based on
diagnostic images from the unaffected breast for cases,
an approach used by others [2]. Although masking may
have led to underestimation of the true magnitude of
the density-risk association [2], this would have affected
all methods similarly. The volumetric methods examined
here attempted to estimate volumetric density from two-
dimensional images, supplemented by information on the
third dimension (using phantoms, breast thickness, plate
tilting). True three-dimensional x-ray breast imaging
techniques, such as tomosynthesis or magnetic resonance
imaging, are not widely used in clinical settings.
Conclusions
Mammographic density offers the potential, alone or in
combination with other genetic and non-genetic factors,
to improve breast cancer risk prediction [25]; to target pri-
mary prevention efforts (for example, chemoprevention,
lifestyle behavioural changes) [27,28]; to tailor screening
according to risk by identifying those who may benefit
from more intensive screening and those for whom
screening may be more harmful than beneficial [29]; and
to monitor response to treatment and risk of adverse
outcomes [30]. However, its applicability in clinical and
screening settings has been hampered by the subjective
and labour-intensive nature of BI-RADS [31-33] and Cu-
mulus, the most widely-used density estimation methods.
Cumulus has been shown to have high between- and
within-reader reliability in research settings [23], in which
efforts are made to train the readers and ensure standard-
isation of procedures, but it is unlikely that similar high
inter-reader reliability values will be observed when
Cumulus is used in clinical/screening practice. This study
demonstrates that fully automated methods are valid alter-
natives for FFDM. The choice of a particular method will
depend on the aims (for example, aetiological investi-
gations versus risk prediction) and setting (for example,
research versus clinical), but the same approach will be
required in longitudinal assessments of density.
Additional files
Additional file 1: Description of the six mammographic density
assessment methods.
Additional file 2: Figure S1. Distributions of absolute density estimates
taken from the left cranio-cauldal (CC)* view for control women, by
method (*except for Quantra, which aggregates data from the two views
to provide a single measurement per breast). Figure S2. Distributions of
breast area/volume estimates taken from the left CC* view for control
women, by method (*except for Quantra, which aggregates data from
the two views to provide a single measurement per breast). Figure S3.
PD readings* from BI-RADS, ImageJ-based method, Volpara, Quantra and
single energy x-ray absorptiometry (SXA) versus those from Cumulus in
control women. *Mean of four breast/view readings per woman
(except for Quantra and SXA - see Methods). Values are plotted on the
appropriate transformed scale (see Methods). Figure S4. Absolute density
readings* from BI-RADS, ImageJ-based method, Volpara, Quantra and SXA
versus those from Cumulus in control women. *Mean of four breast/view
readings per woman (except for Quantra and SXA - see Methods). Values
are plotted on the appropriate transformed scale (see Methods). Figure S5.
Breast area/volume readings* from BI-RADS, ImageJ-based method, Volpara,
Quantra and SXA versus those from Cumulus. *Mean of four breast/view
readings per woman (except for Quantra and SXA - see Methods). Values
are plotted on the appropriate transformed scale (see Methods). Figure S6.
Mutually adjusted association of breast cancer risk factors with absolute
density readings* in control women, by method. HT, hormonal therapy;
OC, oral contraceptives; Pt, P for linear trend. *Mean of four breast/view
readings per woman (except for Quantra and SXA - see Methods).
Figure S7. Mutually adjusted association of breast cancer risk factors with
absolute non-density readings* in control women, by method. HT,
hormonal therapy; OC, oral contraceptives; Pt, P for linear trend. *Mean
of four breast/view readings per woman (except for Quantra and
SXA - see Methods).
Additional file 3: Table S1. Spearman’s rank correlation coefficients (r)
between the various quantitative methods of quantifying percent density
in control women. Table S2. Quintile agreement between the five
quantitative methods of quantifying percent density in control women.
Table S3. Distribution of density readings and level of agreement by
method, breast and view in control women. Table S4. Area under the
receiving operating curve (AUC) for percent and absolute density for
each quantitative method.
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FFDM: full-field digital mammography; HT: hormone therapy; ICC: intra-class
correlation coefficient; MLO: medio-lateral oblique view; OC: oral contraceptives;
OR: odds ratio; PD: percent density; Pt: P for linear trend; SXA: single
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